John Tilton Biohaven Pharmaceutical Holding CO Ltd. (BHVN) insider trading activity
John Tilton is Chief Commercial Officer of Biohaven Pharmaceutical Holding Co Ltd.. Currently has a direct ownership of 1,614 shares of BHVN, which is worth approximately $57,700. The most recent transaction as insider was on Oct 03, 2022, when has been sold 5,068 shares (Common Shares) at a price of $148.5 per share, resulting in proceeds of $752,598. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.61K
0%
3M change
0%
12M change
Total Value Held
$57,700
John Tilton Transaction History
JT
John Tilton
Chief Commercial Officer
New Haven, CT